Sleep and Quality of Life in Multiple Sclerosis

• Conditions: G35.9; G47.9; F32.9; G93.3; Sleep disorder, unspecified; Depressive episode, unspecified; Postviral fatigue syndrome

• Registration Number: DRKS00004970
• Lead Sponsor: niversitätsklinikum Jena

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-05-29
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 2100

Inclusion Criteria

Patients with MS according McDonald`s criteria

Exclusion Criteria

Chronic disease not associated with MS with known impact on sleep quality (neurodegenerative disease, epilepsy, rheumatological diseases, chronic musculoskeletal pain, global respiratory failure, heart failure (NYHA III-IV), alcohol or drug dependence, advanced cancer, renal failure requiring dialysis, psychotic disoders)

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence of Sleep Disorders (Pittsburgh sleep quality index score), study duration: 24 months, patient related study time: 1 h

Secondary Outcome Measures

Name	Time	Method
Specification of Sleep Disorders (hypersomnia, insomnia, sleep apnea, restless legs, narcolepsy, REM-sleep behaviour disorder)